Breast Cancer Genome Guided Therapy Study (BEAUTY)

NCT02022202 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2025-09-03

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to better understand the reasons why or why not breast cancers are destroyed by standard chemotherapy. This information will be used to develop new and better cancer therapies.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Matthew P. Goetz, M.D. · Mayo Clinic

  • Donald W. Northfelt, M.D. · Mayo Clinic campus in Arizona

  • Judy C. Boughey, M.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-03
Primary Completion
2014-05-01
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02022202 on ClinicalTrials.gov